Research

Hormonal

CagriSema (Cagrilintide + Semaglutide) achieves 22.7% weight loss, outperforming semaglutide alone.

CagriSema, a combination of Cagrilintide and Semaglutide, can lead to ~23% weight loss. It is more effective than Semaglutide alone.

GoodSupportsHIGH confidence
Under the “efficacy estimand”—which assumes full adherence to treatment—CagriSema led to a mean weight reduction of 22.7% after 68 weeks, compared to 11.8% with cagrilintide 2.4 mg, 16.1% with semaglutide 2.4 mg, and just 2.3% with placebo.
Safi Alqatari et al. · Medicina · 2025

Why this rating

Phase 3 RCT data.

Source

Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines

Safi Alqatari et al. · Medicina · 2025

DOI 10.3390/medicina61071292

narrative_reviewCited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →